1. Home
  2. NTRA vs STZ Comparison

NTRA vs STZ Comparison

Compare NTRA & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$229.36

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Constellation Brands Inc.

STZ

Constellation Brands Inc.

HOLD

Current Price

$137.71

Market Cap

24.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
STZ
Founded
2003
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
24.8B
IPO Year
2015
1987

Fundamental Metrics

Financial Performance
Metric
NTRA
STZ
Price
$229.36
$137.71
Analyst Decision
Strong Buy
Buy
Analyst Count
15
19
Target Price
$238.20
$173.21
AVG Volume (30 Days)
1.2M
2.5M
Earning Date
11-06-2025
01-07-2026
Dividend Yield
N/A
2.91%
EPS Growth
N/A
116.70
EPS
N/A
6.84
Revenue
$2,116,676,000.00
$9,624,000,000.00
Revenue This Year
$33.18
N/A
Revenue Next Year
$16.81
$0.32
P/E Ratio
N/A
$20.48
Revenue Growth
38.17
N/A
52 Week Low
$125.38
$126.45
52 Week High
$246.90
$228.89

Technical Indicators

Market Signals
Indicator
NTRA
STZ
Relative Strength Index (RSI) 52.01 47.38
Support Level $227.89 $137.41
Resistance Level $237.04 $142.92
Average True Range (ATR) 5.07 3.56
MACD -1.57 -0.62
Stochastic Oscillator 49.47 21.01

Price Performance

Historical Comparison
NTRA
STZ

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands, effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Share on Social Networks: